Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Clinical trial NCT04793958 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04793958
- Sponsor
- Mirati Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2026-01-16
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.